These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30767394)

  • 1. Effects of solvent used for fabrication on drug loading and release kinetics of electrosprayed temozolomide-loaded PLGA microparticles for the treatment of glioblastoma.
    Rodriguez de Anda DA; Ohannesian N; Martirosyan KS; Chew SA
    J Biomed Mater Res B Appl Biomater; 2019 Oct; 107(7):2317-2324. PubMed ID: 30767394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Caspase-Mediated Abrogation of Autophagy by Temozolomide-Loaded and Panitumumab-Conjugated Poly(lactic-
    Banstola A; Duwa R; Emami F; Jeong JH; Yook S
    Mol Pharm; 2020 Nov; 17(11):4386-4400. PubMed ID: 33079558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer.
    Shapira-Furman T; Serra R; Gorelick N; Doglioli M; Tagliaferri V; Cecia A; Peters M; Kumar A; Rottenberg Y; Langer R; Brem H; Tyler B; Domb AJ
    J Control Release; 2019 Feb; 295():93-101. PubMed ID: 30605703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of electrosprayed minocycline-loaded PLGA microparticles for the treatment of glioblastoma.
    Arriaga MA; Amieva JA; Quintanilla J; Jimenez A; Ledezma J; Lopez S; Martirosyan KS; Chew SA
    Biotechnol Bioeng; 2023 Nov; 120(11):3409-3422. PubMed ID: 37605630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Anti-Tumor Activity in Mice with Temozolomide-Resistant Human Glioblastoma Cell Line-Derived Xenograft Using SN-38-Incorporated Polymeric Microparticle.
    Yang TC; Liu SJ; Lo WL; Chen SM; Tang YL; Tseng YY
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34074038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temozolomide-loaded PLGA nanoparticles to treat glioblastoma cells: a biophysical and cell culture evaluation.
    Ananta JS; Paulmurugan R; Massoud TF
    Neurol Res; 2016 Jan; 38(1):51-9. PubMed ID: 26905383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy.
    Kadhim ZA; Sulaiman GM; Al-Shammari AM; Khan RA; Al Rugaie O; Mohammed HA
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy.
    Mao J; Meng X; Zhao C; Yang Y; Liu G
    Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verteporfin-Loaded Polymeric Microparticles for Intratumoral Treatment of Brain Cancer.
    Shah SR; Kim J; Schiapparelli P; Vazquez-Ramos CA; Martinez-Gutierrez JC; Ruiz-Valls A; Inman K; Shamul JG; Green JJ; Quinones-Hinojosa A
    Mol Pharm; 2019 Apr; 16(4):1433-1443. PubMed ID: 30803231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
    Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
    Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel PLGA nanoparticles with co-encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells.
    Sokol MB; Nikolskaya ED; Yabbarov NG; Zenin VA; Faustova MR; Belov AV; Zhunina OA; Mollaev MD; Zabolotsky AI; Tereshchenko OG; Severin ES
    J Biomed Mater Res B Appl Biomater; 2019 May; 107(4):1150-1158. PubMed ID: 30281905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Efficacy of Temozolomide Loaded by a Tetrahedral Framework DNA Nanoparticle in the Therapy for Glioblastoma.
    Fu W; You C; Ma L; Li H; Ju Y; Guo X; Shi S; Zhang T; Zhou R; Lin Y
    ACS Appl Mater Interfaces; 2019 Oct; 11(43):39525-39533. PubMed ID: 31601097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and characterization of poly(propylacrylic acid)/poly(lactic-co-glycolic acid) blend microparticles for pH-dependent membrane disruption and cytosolic delivery.
    Fernando LP; Lewis JS; Evans BC; Duvall CL; Keselowsky BG
    J Biomed Mater Res A; 2018 Apr; 106(4):1022-1033. PubMed ID: 29164777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of microparticles for controlled release of resveratrol to adipose tissue and the impact of drug loading on particle morphology and drug release.
    Isely C; Hendley MA; Murphy KP; Kader S; Annamalai P; Jabbari E; Gower RM
    Int J Pharm; 2019 Sep; 568():118469. PubMed ID: 31265884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles.
    Zhu X; Lu L; Currier BL; Windebank AJ; Yaszemski MJ
    Biomaterials; 2002 Jul; 23(13):2683-92. PubMed ID: 12059017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release of paclitaxel using a drug-eluting stent through modulation of the size of drug particles in vivo.
    Jang BN; Kang SN; Eom TG; Han DK; An SH; Noh I; Kum CH
    J Biomed Mater Res B Appl Biomater; 2018 Aug; 106(6):2275-2283. PubMed ID: 29087014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
    Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V
    Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan-PLGA mucoadhesive nanoparticles for gemcitabine repurposing for glioblastoma therapy.
    Ramalho MJ; Serra É; Lima J; Loureiro JA; Pereira MC
    Eur J Pharm Biopharm; 2024 Jul; 200():114326. PubMed ID: 38759897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of PLGA nanoparticles for sustained release of a connexin43 mimetic peptide to target glioblastoma cells.
    Roberts R; Smyth JW; Will J; Roberts P; Grek CL; Ghatnekar GS; Sheng Z; Gourdie RG; Lamouille S; Foster EJ
    Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110191. PubMed ID: 31923988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.